Individual outcomes | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Primary composite outcome* | Diseases of prematurity$ | Ventilation > 1 day | Neonatal intensive care unit admission | Perinatal death | ||||||
Type of antihypertensive therapy | Rate (%)** | Adjusted OR (95% CI)# | Rate (%) | Adjusted OR (95% CI) | Rate (%) | Adjusted OR (95% CI) | Rate (%) | Adjusted OR (95% CI) | Rate (%) | Adjusted OR (95% CI) |
None | 19.5 | 1.0 | 15.1 | 1.0 | 3.4 | 1.0 | 27.4 | 1.0 | 1.9 | 1.0 |
β-blocker | 30.9 | 1.4 (0.9–2.2) | 26.2 | 1.4 (0.9–9.2) | 10.9 | 2.3 (0.9–5.9) | 48.7 | 2.4 (1.6–3.5) | 3.7 | 1.5 (0.6–3.4) |
Non-β-blocker | 56.7 | 5.0 (2.6–9.6) | 49.1 | 4.4 (2.1–9.2) | 24.6 | 6.9 (2.3–20.6) | 77.2 | 9.9 (4.7–21.0) | 5.8 | 2.6 (1.1–6.3) |
Both β-blocker and non-β-blocker | 59.2 | 2.9 (1.8–4.7) | 55.6 | 2.8 (1.7–4.8) | 31.0 | 3.7 (1.4–9.4) | 87.4 | 18.2 (10.9–30.4) | 7.1 | 3.1 (1.4–6.8) |